BIT vs IDT

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

BIT

BIOTRON FPO [BIT]

42LOW

IDT

IDT AUST FPO [IDT]

43LOW

Score Breakdown

BIT IDT
Technical
31
53
Catalyst
50
50
Sentiment
50
50
Fundamental
38
66
Momentum
57
27
Risk Gate
35
38

Key Metrics

BIT Metric IDT
$8.1MMarket Cap$19.2M
3.3MAvg Volume (20d)92K
N/AShort InterestN/A
$0.00552-Week High$0.115
$0.00252-Week Low$0.041
+0.0%Daily Change+0.0%
$0.003Entry Price$0.045
-122.6%ROE-26.1%
N/AProfit Margin-32.3%

Active Signals

BIT Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Volume surging at 2.2x normal while price falls — heavy selling pressure
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Low cash runway (3 quarters) - dilution risk
Piotroski F-Score weak (3/9, low-confidence approx)

IDT Signals

MACD just crossed bullish — momentum is shifting to the upside
Volume surging at 2.5x normal while price falls — heavy selling pressure
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.0x)
Revenue declining (-7%)
EPS estimates revised upward (+10pts)
Near 52-week low (5% of range)

Ask Scout AI to compare BIT and IDT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BIT Full Analysis → IDT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).